4.50
price down icon0.44%   -0.02
after-market Handel nachbörslich: 4.41 -0.09 -2.00%
loading
Schlusskurs vom Vortag:
$4.52
Offen:
$4.51
24-Stunden-Volumen:
1.80M
Relative Volume:
1.28
Marktkapitalisierung:
$1.73B
Einnahmen:
$775.09M
Nettoeinkommen (Verlust:
$-58.68M
KGV:
-33.94
EPS:
-0.1326
Netto-Cashflow:
$64.06M
1W Leistung:
-3.02%
1M Leistung:
-9.64%
6M Leistung:
-34.31%
1J Leistung:
-36.62%
1-Tages-Spanne:
Value
$4.43
$4.75
1-Wochen-Bereich:
Value
$4.43
$4.79
52-Wochen-Spanne:
Value
$4.09
$9.2599

Goodrx Holdings Inc Stock (GDRX) Company Profile

Name
Firmenname
Goodrx Holdings Inc
Name
Telefon
(855) 268-2822
Name
Adresse
2701 OLYMPIC BOULEVARD, SANTA MONICA
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
GDRX's Discussions on Twitter

Vergleichen Sie GDRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Health Information Services icon
GDRX
Goodrx Holdings Inc
4.50 1.73B 775.09M -58.68M 64.06M -0.1326
Health Information Services icon
VEEV
Veeva Systems Inc
234.21 38.81B 2.75B 714.14M 1.09B 4.33
Health Information Services icon
SOLV
Solventum Corp
74.75 12.84B 8.26B 66.00M 1.17B 0.3682
Health Information Services icon
DOCS
Doximity Inc
58.51 11.36B 516.85M 174.11M 217.38M 0.87
Health Information Services icon
TEM
Tempus Ai Inc
47.83 10.16B 640.44M -743.28M -206.93M -11.29
Health Information Services icon
HQY
Healthequity Inc
86.96 7.54B 1.15B 96.70M -161.99M 1.09

Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-04 Eingeleitet Mizuho Neutral
2024-08-09 Hochstufung Raymond James Outperform → Strong Buy
2024-05-23 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2024-05-16 Hochstufung Raymond James Mkt Perform → Outperform
2024-04-10 Hochstufung KeyBanc Capital Markets Sector Weight → Overweight
2024-03-25 Hochstufung Wells Fargo Equal Weight → Overweight
2024-03-01 Hochstufung JP Morgan Neutral → Overweight
2024-02-26 Eingeleitet Leerink Partners Outperform
2024-01-02 Herabstufung BofA Securities Buy → Underperform
2023-08-10 Hochstufung DA Davidson Neutral → Buy
2023-07-31 Hochstufung TD Cowen Market Perform → Outperform
2022-12-01 Eingeleitet Citigroup Buy
2022-11-04 Hochstufung JP Morgan Underweight → Neutral
2022-09-16 Eingeleitet KeyBanc Capital Markets Sector Weight
2022-09-07 Eingeleitet Truist Hold
2022-08-12 Eingeleitet DA Davidson Neutral
2022-06-10 Herabstufung Goldman Buy → Neutral
2022-06-06 Fortgesetzt BofA Securities Buy
2022-06-01 Herabstufung Robert W. Baird Outperform → Neutral
2022-05-10 Herabstufung Evercore ISI Outperform → In-line
2022-05-10 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2022-05-10 Herabstufung Raymond James Outperform → Mkt Perform
2022-05-10 Herabstufung SVB Leerink Outperform → Mkt Perform
2022-04-11 Eingeleitet Wells Fargo Equal Weight
2022-04-07 Eingeleitet Guggenheim Buy
2022-04-01 Fortgesetzt Credit Suisse Neutral
2022-03-15 Hochstufung Robert W. Baird Neutral → Outperform
2022-03-01 Bestätigt Barclays Overweight
2022-03-01 Bestätigt BofA Securities Neutral
2022-03-01 Herabstufung Cowen Outperform → Market Perform
2022-03-01 Herabstufung Credit Suisse Outperform → Neutral
2022-03-01 Bestätigt Evercore ISI Outperform
2022-03-01 Bestätigt Goldman Buy
2022-03-01 Bestätigt JP Morgan Underweight
2022-03-01 Bestätigt RBC Capital Mkts Outperform
2022-03-01 Bestätigt SVB Leerink Outperform
2022-01-07 Eingeleitet Goldman Buy
2021-12-21 Eingeleitet Stephens Overweight
2021-12-02 Eingeleitet Jefferies Buy
2021-08-31 Hochstufung Barclays Equal Weight → Overweight
2021-08-13 Hochstufung Raymond James Mkt Perform → Outperform
2021-05-28 Eingeleitet Robert W. Baird Neutral
2021-04-06 Fortgesetzt Evercore ISI Outperform
2021-01-25 Eingeleitet Guggenheim Buy
2020-11-19 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2020-11-18 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-10-19 Eingeleitet Barclays Equal Weight
2020-10-19 Eingeleitet BofA Securities Neutral
2020-10-19 Eingeleitet Citigroup Buy
2020-10-19 Eingeleitet Cowen Outperform
2020-10-19 Eingeleitet Credit Suisse Outperform
2020-10-19 Eingeleitet Deutsche Bank Hold
2020-10-19 Eingeleitet Goldman Neutral
2020-10-19 Eingeleitet JP Morgan Neutral
2020-10-19 Eingeleitet Morgan Stanley Overweight
2020-10-19 Eingeleitet RBC Capital Mkts Sector Perform
2020-10-19 Eingeleitet SVB Leerink Outperform
2020-10-19 Eingeleitet UBS Buy
Alle ansehen

Goodrx Holdings Inc Aktie (GDRX) Neueste Nachrichten

pulisher
Mar 27, 2025

Levi & Korsinsky Notifies GoodRx Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineGDRX - ACCESS Newswire

Mar 27, 2025
pulisher
Mar 27, 2025

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital - Yahoo Finance

Mar 27, 2025
pulisher
Mar 25, 2025

Do Fundamentals Have Any Role To Play In Driving GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Stock Up Recently? - Simply Wall St

Mar 25, 2025
pulisher
Mar 24, 2025

GoodRx: Great Value For Patient Investors (Upgrade) (NASDAQ:GDRX) - Seeking Alpha

Mar 24, 2025
pulisher
Mar 17, 2025

PBMs Hit With Antitrust Suit Over GoodRx Generics Program - Law360

Mar 17, 2025
pulisher
Mar 17, 2025

GoodRx Strengthens Leadership: $100M Revenue Leader Takes President Role - StockTitan

Mar 17, 2025
pulisher
Mar 13, 2025

GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Sold by US Bancorp DE - Defense World

Mar 13, 2025
pulisher
Mar 10, 2025

GoodRx Holdings, Inc. (GDRX): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? - Insider Monkey

Mar 10, 2025
pulisher
Mar 07, 2025

GoodRx Holdings, Inc. (GDRX): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts - Insider Monkey

Mar 07, 2025
pulisher
Mar 07, 2025

GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

12 Cash-Rich Penny Stocks To Buy According To Hedge Funds - Insider Monkey

Mar 06, 2025
pulisher
Mar 03, 2025

Shareholders of GoodRx Holdings, Inc. Should Contact Levi & Korsinsky Before June 21, 2024 to Discuss Your RightsGDRX - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 03, 2025

Investors in GoodRx Holdings, Inc. Should Contact Levi & Korsinsky Before June 21, 2024 to Discuss Your RightsGDRX - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 03, 2025

Wells Fargo & Company Cuts GoodRx (NASDAQ:GDRX) Price Target to $8.00 - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Levi & Korsinsky Notifies Shareholders of GoodRx Holdings, Inc.(GDRX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Mar 02, 2025
pulisher
Feb 28, 2025

GoodRx Holdings, Inc. (GDRX) Q4 Earnings Match Estimates - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

GoodRx Holdings, Inc. (NASDAQ:GDRX) Q4 2024 Earnings Call Transcript - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of GoodRx Holdings, Inc.(GDRX) Shareholders - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

The Analyst Verdict: GoodRx Holdings In The Eyes Of 4 Experts - Benzinga

Feb 28, 2025
pulisher
Feb 28, 2025

Investors who lost money on GoodRx Holdings, Inc.(GDRX) should contact Levi & Korsinsky about pending Class ActionGDRX - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

GoodRx Holdings Leads The Charge With These 3 Promising Penny Stocks - Simply Wall St

Feb 28, 2025
pulisher
Feb 28, 2025

Decoding GoodRx Holdings Inc (GDRX): A Strategic SWOT Insight - GuruFocus.com

Feb 28, 2025
pulisher
Feb 28, 2025

GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription Sales - Benzinga India

Feb 28, 2025
pulisher
Feb 28, 2025

GoodRx Holdings Inc (GDRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Feb 28, 2025
pulisher
Feb 27, 2025

GoodRx Holdings Reports Strong 2024 Financial Results - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

GoodRx Earnings Call: Growth Amid Challenges - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Citi raises GoodRx stock target to $6.75, maintains buy rating By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

GoodRx Holdings IncOrdinary SharesClass A to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

Citi raises GoodRx stock target to $6.75, maintains buy rating - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Insights Into GoodRx (GDRX) Q4: Wall Street Projections for Key Metrics - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

Raymond James Reiterates Strong Buy Rating on GoodRx Holdings Inc. (GDRX) - StreetInsider.com

Feb 27, 2025
pulisher
Feb 27, 2025

GoodRx Holdings Inc. (GDRX) PT Raised to $6.75 at Citi - StreetInsider.com

Feb 27, 2025
pulisher
Feb 27, 2025

GoodRx shares rise on upbeat Q1 guidance despite Q4 miss By Investing.com - Investing.com Australia

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: GoodRx Q4 2024 misses EPS forecast, stock rises - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

GoodRx Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Here's What Key Metrics Tell Us About GoodRx (GDRX) Q4 Earnings - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

GoodRx Q4 Adjusted Earnings, Revenue Rise; Q1, 2025 Revenue Guidance Issued - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

GoodRx Reports Fourth Quarter and Full Year 2024 Results - 01Net

Feb 27, 2025
pulisher
Feb 27, 2025

GoodRx Holdings Sees Increased Revenue In Q1, Full YearUpdate - Nasdaq

Feb 27, 2025
pulisher
Feb 27, 2025

GOODRX Earnings Results: $GDRX Reports Quarterly Earnings - Nasdaq

Feb 27, 2025
pulisher
Feb 27, 2025

BRIEF-GoodRx Holdings Q4 Adjusted Net Income USD 34.7 Million Vs. IBES Estimate USD 37.4 Million - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

GoodRx Holdings, Inc. (GDRX) Misses Q4 EPS by 1c ; Offers Guidance - StreetInsider.com

Feb 27, 2025
pulisher
Feb 26, 2025

GoodRx Earnings: What To Look For From GDRX By Stock Story - Investing.com Canada

Feb 26, 2025
pulisher
Feb 26, 2025

GoodRx Earnings: What To Look For From GDRX - The Globe and Mail

Feb 26, 2025
pulisher
Feb 26, 2025

GoodRx Holdings Inc (GDRX) Q4 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Feb 26, 2025
pulisher
Feb 25, 2025

GoodRx’s SWOT analysis: prescription savings leader faces pharmacy headwinds - Investing.com

Feb 25, 2025

Finanzdaten der Goodrx Holdings Inc-Aktie (GDRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$19.14
price down icon 0.26%
$22.59
price down icon 1.44%
$18.03
price down icon 2.06%
health_information_services WAY
$37.83
price down icon 1.84%
health_information_services HQY
$86.96
price down icon 2.11%
Kapitalisierung:     |  Volumen (24h):